Almost every conversation about health cover in Indonesia starts in the wrong place: whether BPJS is good or bad. It is neither. It is a national scheme with a specific design, and once you understand the design you can see exactly where it protects you and where it hands the problem back.
It covers treatment, not convenience
BPJS pays for medically necessary care through a tiered referral system. You start at a first-level facility, a puskesmas or a registered clinic, and move up only with a referral, except in a genuine emergency. That structure is what keeps the scheme affordable. It is also why people who expect to walk into a large private hospital and be treated the same afternoon feel let down.
The practical consequence is time. For a routine illness, time is an inconvenience. For a suspicious lump, time is the whole story.
Your class sets your ceiling, not just your room
Class determines the room you are entitled to, and room class feeds into a number of the tariff calculations behind your treatment. If you upgrade beyond your entitlement, the difference is yours to pay, and on a long admission that difference is not small.
Some things sit outside the scheme entirely
Cosmetic procedures, infertility treatment, self-inflicted injury, and care obtained abroad generally fall outside. So do certain newer drugs that have not been listed in the national formulary, which matters most in oncology, where the newest therapies are often the ones being discussed.
The gap that actually hurts
The number that damages families is rarely the hospital bill alone. It is the bill plus the months of lost income while someone recovers, or while a spouse stops working to be a carer. BPJS was never designed to replace income. Nothing in the scheme does that.
So the honest way to think about it: keep BPJS, always. Then ask a much narrower question, what would this specific illness cost me in money I still have to earn?